Figure 3From: Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies Forest plots of pooled results (A, recurrence-free survival; B, progression-free survival) for the low-dose group and standard-dose group. Back to article page